Abstract
Dengue is a mild flu-like arboviral illness caused by dengue virus (DENV) that occurs in tropical and subtropical countries. An increasing number of reports have been indicating that dengue is also associated to neurological manifestations, however, little is known regarding the neuropathogenesis of the disease. Here, using BALB/c mice intravenously infected with DENV-2 strain 66985, we demonstrated that the virus is capable of invading and damaging the host’s central nervous system (CNS). Brain and cerebellum of infected animals revealed histological alterations such as the presence of inflammatory infiltrates, thickening of pia matter and disorganization of white matter. Additionally, it was also seen that infection lead to altered morphology of neuroglial cells and apoptotic cell death. Such observations highlighted possible alterations that DENV may promote in the host’s CNS during a natural infection, hence, helping us to better understand the neuropathological component of the disease.
Introduction
Dengue is a mosquito-borne disease that represents a major health problem especially in tropical and subtropical regions worldwide. The disease is caused by dengue virus (DENV), which comprises four antigenically different serotypes (DENV-1 to DENV-4) belonging to the Flaviviridae family. Dengue burden has been expanding since 1960s as it grew side by side with the world’s population. Nowadays, around 390 million people are infected every year, of which about 25% are of clinical relevance1. Symptoms of dengue are usually similar to the regular flu, however, a small fraction of cases may evolve to a severe hemorrhagic form that is eventually responsible for about 20,000 deaths in an annual basis2,3.
An intriguing fact that has drawn attention in dengue is the involvement of the host’s central nervous system (CNS) in the course of infection. CNS-related symptoms of dengue were first reported as an acute encephalopathy in 19764 and, classically, these manifestations have been treated as rare phenomena in humans5,6. Back in 1998, Ramos and coworkers suggested that DENV neurotropism was based on opportunism7. However, a growing number of reports showing the presence of the virus in the host’s CNS8–12 supported the idea that the neurotropic property would be an intrinsic characteristic of the virus. After being vastly reported in 25 countries spread across different continents13–22, neurological signs in dengue were grouped into 3 sub-classifications: (i) encephalopathy; (ii) neuromuscular complications; and (iii) neuro-ophthalmic involvements. The incidence rate of such symptoms varied from 0.5 to 20% among patients admitted to hospitals23. Additionally, neurological signs of subjective nature and of difficult characterization, such as restlessness, irritability, dizziness, drowsiness and stupor, were also associated to the disease24. Considering the increased frequency of CNS-related symptoms in patients with dengue, neurological manifestations were officially recognized by the World Health Organization (WHO) and listed as part of the differential diagnosis for severe dengue in 200925. Despite this official recognizance, information regarding the neuropathological basis of the disease is still scarce and demanding of research.
In an attempt to describe the impact of DENV infection in the host’s CNS, BALB/c mice were infected with patient-isolated DENV-2 by the intravenous (i.v.) route. Despite the absence of apparent symptoms, mice responded to the infection with antigen presenting cell (APC) induction and TCD8 cell activation. Histological analyses of the infected animals’ brain and cerebellum revealed pathological alterations such as presence of inflammatory infiltrates, thickening of pia matter and disorganization of white matter in the brain; and altered Purkinje neurons, hemorrhage and demyelination in the cerebellum. Analysis of microglia (IBA-1+) and astrocytes (GFAP+) in the brain showed that these subpopulations were morphologically altered in infected mice. Electron microscopy analyses of brain and cerebellum from DENV-infected mice revealed cellular impairments that suggested apoptotic induction. We also found that DENV was able to reach the host’s CNS upon i.v. inoculation, as detected by DENV-NS3 staining, supporting the natural neurotropic behavior of the virus and suggesting that the observed effects were due to direct viral infection in the CNS. Such findings highlighted possible brain alterations that could yield CNS-related symptoms in dengue and helped us to better understand the neuropathological component of the disease.
Results
DENV infection in BALB/c mice induces TCD8-mediated cellular immunity
In the experiments considered here, BALB/c mice were infected with patient-isolated DENV-2 by the intravenous (i.v.) route. It was previously demonstrated that although the infection is not capable of producing symptoms, it can induce hepatic injury in the subjects and virus can be detected in different cell types such as hepatocytes, Kupffer cells and endothelium26. Given the influence that the cellular immunity may have towards the neurological involvement in dengue17,19,27, our initial step here was to address the immunological status of these mice upon the i.v. infection.
Spleen and blood samples of infected animals were evaluated by flow cytometry two and seven days post infection (d.p.i.). When analyzing the spleen of infected mice, we observed relevant increments in the percentages of CD86+ CD11c+ cells (which we considered as the antigen presenting cell subset - APC) on the 2nd and on the 7th d.p.i., in comparison to controls. Of note, on the 7th d.p.i. the percentage of CD86+ CD11c+ cells reached approximately 2 times higher than the observed in the mock-infected group (Fig. 1A). This finding suggested that the i.v. infection induced activation and migration of APCs to the lymphoid organ in order to trigger specific immunity. Under this line of thinking, we next checked the levels of activated lymphocytes present in the circulation of the infected mice. Flow cytometry data revealed that on the 7th d.p.i. the percentage of CD8+ CD45RBlow (considered as the activated TCD8 cells) consistently increased when compared to mock or to the 2nd d.p.i. groups (Fig. 1B). No statistically relevant variations were seen in the percentages of circulating CD4+ CD45RBlow cells considering all the analyzed groups. These data indicated that, upon infection, the animals were able to trigger specific immunity to DENV-2 with the activation of TCD8 lymphocytes.
BALB/c mice present damage in the CNS after DENV infection by the i.v route
In the previous evaluation, the occurrence of activated lymphocytes in the circulation of infected mice draw our attention for a possible targeting of T-cell migration to host’s tissues. To address the involvement of infection and a possible impact of the cellular immunity in the CNS we proceeded with histological studies considering the brain and the cerebellum tissues. Four major areas were took into account for investigation: (i) the cerebral cortex, which comprises the sensory and motor areas of the brain; (ii) the hippocampus, which consists of an internal area of the brain related to memory; (iii) the cerebral white matter, a region of myelinated nerve fibers that is critical for the axonal signaling and flux; and (iv) the cerebellum, a structure that plays a crucial role in motor control28.
Considering the samples from infected mice, histopathological analyses showed damage in the brain and cerebellum tissues. On the 2nd d.p.i., the cerebral cortex showed thickening of the pia mater with an increased cellularity (Fig. 2B) and focal perivascular inflammatory infiltrate consisting mainly of lymphocytes and glial cells (Fig. 2C). On the 7th d.p.i., the inflammatory infiltrates were more diffuse by the parenchyma with predominance of microglial cells (Fig. 2D). As expected, brain of non-infected mice showed pia mater, molecular layer, granular layer, pyramidal neurons layer and white matter with regular structures (Fig. 2A). When analyzing the white matter from infected mice we found that this region was structurally disorganized. On the 2nd d.p.i. this area was marked by microglial cell infiltrates within the parenchyma (Fig. 2F), while later on the 7th d.p.i. the cell infiltrates were more characterized around blood vessels (Fig. 2G). Regarding the hippocampus area, while non-infected mice exhibited regular structures (Fig. 2H,I), infected animals showed presence of neuroglial cells infiltrates within this region. In this case, on the 2nd d.p.i. infiltrates were seen in the CA1 (Cornu Ammonis 1) region (Fig. 2J), while on the 7th d.p.i. this manifestation occurred mainly in the CA3 (Cornu Ammonis 3) (Fig. 2K).
Analyses of the cerebellum tissue collected from infected animals revealed inflammatory infiltrates in the pia mater. Purkinje neurons were also characterized by altered morphology on the 2nd d.p.i. (Fig. 2M). On the 7th d.p.i., it was observed an extensive area of demyelination with presence of microglial cells in the white matter (Fig. 2N) and circulatory damage such as hemorrhage in the cerebellar parenchyma (Fig. 2O). Control mice showed cerebellum structures with regular aspects (Fig. 2L).
In order to identify the extent of brain damage caused by DENV-2 strain 66985, three histopathological parameters were quantified: (i) hemorrhage; (ii) perivascular infiltrate; and (iii) pia mater infiltrate. Although the infection could lead to brain hemorrhage, this morphological change was mostly focal and limited to small areas. In average, on the 2nd d.p.i. there were only 2 positive fields out of 30, while on the 7th d.p.i. this damage was found in a more spread fashion (in average 4 positive fields out of 30) but still rarely observed (Fig. 3 left). Perivascular and pia mater infiltrates behaved similarly, however at different magnitudes, being more evident on the 7th d.p.i., when compared to the 2nd d.p.i. In average, considering perivascular infiltrates, on the 2nd d.p.i. there were approximately 6 positive fields out of 30, while on the 7th d.p.i. this margin was increased up to 11 positive fields out of 30 (Fig. 3 center). Infiltrates in the pia mater were averaged as 4 positive fields out of 30 on the 2nd d.p.i. and 7 positive fields out of 30 towards the 7th d.p.i. (Fig. 3 right). No histological alterations were observed in the controls.
Infected animals reveal morphological alterations of microglial cells and astrocytes
After characterizing tissue alterations in the brain and cerebellum of DENV-infected animals, we considered investigating the brain cellular components responsible for tissue homeostasis. For this, we analyzed in more detail the neuroglial cells, in particular microglial cells and astrocytes, since they are known to play critical roles in maintaining CNS’ homeostasis, supporting and protecting neurons from injury29,30.
In samples collected from non-infected mice, microglial cells (IBA-1+ cells) were detected in the cortex and white matter. This cell population was found exhibiting scarce cytoplasm, long/thin extensions (Fig. 4A) and assuming a ramified morphology, which is known to be typical of their surveillant and homeostatic state. In the samples from infected animals, these cells were characterized by ameboid morphology with retracted extensions and increased cytoplasm located in the cortex (Fig. 4B) as well as in the white matter close to the capillaries (Fig. 4C). This morphological characterization, which is typical from their activated state, was observed mainly on the 2nd d.p.i. Based on morphology, later at the 7th d.p.i. these cells seemed to return to their regular activity/processes (as seen by their ramified appearance) both in the cortex (Fig. 4D) and in the white matter (Fig. 4E). Astrocytes (GFAP+ cells) in non-infected mice showed thin appearance in the cortex (Fig. 4F) and in the white matter (Fig. 4G). In the samples from infected mice, GFAP+ cells were found under a degenerative process with atrophy of their cytoplasmic extensions on the 2nd d.p.i. (Fig. 4H). On the 7th d.p.i., astrocytes assumed large and thick shapes with thicker cytoplasmic extensions either in the cerebral cortex or in the white matter (Fig. 4I,J).
In order to identify whether the CNS was committed by reactive microgliosis or astrogliosis, we proceeded with the quantification of both IBA-1+ and GFAP+ cells within the cerebral cortex and white matter. As shown in the Fig. 4 panels k and l, both cell types statistically increased in number on the 7th d.p.i., when compared to controls. This finding confirmed the occurrence of reactive microgliosis and astrogliosis upon infection with DENV by the i.v. route.
Ultrastructural aspects of brain and cerebellum from DENV-infected mice
To obtain a better description of the cellular changes in the CNS originated upon infection with DENV, ultrastructural evaluations were performed using electron microscopy. Brain and cerebellum tissues from infected mice showed degenerated pyramidal and Purkinje neurons with irregular nuclear membrane and mitochondria swelling (Figs 5B and 6B). In the same analyzed sites, microglial cells exhibited increased nucleus and loss of integrity of mitochondrial ridges (Figs 5D and 6D). Brain astrocytes showed a deposition of heterochromatin in a cell pole (Fig. 5F). In the cerebellum, there was disorganization of the myelin fiber pattern suggesting a process of demyelinating neuropathy (Fig. 6F), which corroborated with the findings from the histopathological analyses. Samples collected from control mice exhibited regular structures of pyramidal and Purkinje neurons (Fig. 5A and 6A), microglial cells (Fig. 5C and 6C), astrocytes (Fig. 5E) and myelin fibers (Fig. 6E).
Viral detection in the SNC of DENV-infected mice
To address the viral presence and its ongoing replicative process in the CNS we performed immunostaining of DENV-NS3 protein, since this viral antigen is only expressed upon viral replication. DENV-NS3 protein was found in endothelial cells of the cerebral cortex and hippocampus (Fig. 7B,F), microglial cells of the hippocampus and cerebellum (Fig. 7E,J) and in Purkinje neurons on the 2nd d.p.i. (Fig. 7I). On the 7th d.p.i., DENV-NS3 was present in microglial cells of the cerebral cortex (Fig. 7C), granular cells of the hippocampus (Fig. 7G), neurons and endothelial cells in the cerebellum (Fig. 7K,L).
Measurement of viral titers in the infected brains
Brain cuts from infected mice showed clear expression of DENV-NS3 in several cell types. In order to strengthen this observation a new round of experiment was performed in which brains from infected animals were collected on the 2nd (10 mice) and on the 7th d.p.i. (9 mice). Mock-infected controls (4 animals per group) were also taken into account on the 2nd and on the 7th day after inoculation. While all controls were negative, four animals out of ten had their brain tissue positive for DENV-RNA on the 2nd d.p.i. with titers of 3.72 × 104, 5.68 × 104, 6.02 × 103 or 9.19 × 102 RNA copies/mL. Two animals out of nine were positive for DENV-RNA in their brains on the 7th d.p.i. with titers of 3.80 × 104 or 2.26 × 103 RNA copies/mL.
Discussion
In this work, using BALB/c animals inoculated with DENV-2 strain 66985 by the i.v. route, we characterized several alterations in the CNS of infected mice which could be correlated with the neurological component of the disease. We identified that brain and cerebellum tissues extracted from DENV-infected animals presented cellular damage, tissue disorganization, morphological alterations of microglia and astrocytes (cells that provide support and homeostatic balance to neurons) and ultrastructural cellular impairments that suggested apoptotic induction. We also found that DENV was able to reach the brain and cerebellum tissues of mice upon i.v. inoculation, an observation that supported the natural neurotropic behavior of the considered viral strain.
Although the infected animals presented these CNS alterations, an intriguing observation that must be taken into account is that the animals were not phenotypically influenced after virus inoculation. Survival rates were not affected by the infection. Additionally, previous observations showed that animals remained apparently asymptomatic for at least 50 days after viral inoculation26. We consider that the absence of clinical effects in infected mice, such as altered motor coordination for example, did not exclude the possibility of other existing effects affecting the CNS. A study that corroborates with this line of thinking is from Huy and colleagues that by means of a meta-analytical study identified that clinical manifestations, such as, restlessness, irritability, dizziness, drowsiness and stupor have been associated to the disease24. Given the empirical nature in assessing these clinical parameters in animal models, it becomes difficult to categorically affirm whether infected mice were experiencing neurological symptoms at this peculiar level or not. Another fact that may have contributed to the absence of apparent CNS-related effects in infected mice is that immunocompetent animals are naturally resistant to DENV infection. It was seen that DENV is not able to subvert the IFN-α/β antiviral response in mice31–33 as it happens in humans34–42. Despite this resistance, immunocompetent mice can still be infected as evidenced in other mouse models of dengue26,43–46. However, these animal models do not reproduce the full specter of symptoms as characterized in humans. In our experimental approach, even considering this phenotypic peculiarity, we could observe signs of host response to the infection, such as APC induction and TCD8 cell activation. Additionally, by an unrecognized mechanism, viruses were able to cause blood-brain barrier dysfunction and infect brain and cerebellum cells. One hypothesis to explain this scenario is that the immune-privileged characteristic of the brain may be related to increased permissiveness of viral replication in this site. Our data also showed that the infection leads to circulatory disturbances (hemorrhage), which on its own infers changes in the permeability of the blood-brain barrier. Although hemorrhagic events were scarce, they would have been sufficient to cause an early outbreak of the virus (on the 2nd d.p.i.) from the circulation to the brain.
Among the tissue alterations found in the infected mice, we observed inflammatory infiltrates, thickening of pia matter, increased number of activated neuroglial cells and DENV-NS3 expression in brain and cerebellum cells. Such alterations were in accordance with the study from Amaral and coworkers, in which after infecting C57BL/6 mice intracerebrally with DENV-3, the following changes were observed: (i) increased leukocyte rolling and adhesion in brain microvasculature; (ii) tissue evidences of meningoencephalitis, such as perivascular hemorrhages and infiltration of mononuclear cells in brain and cerebellum; (iii) reactive gliosis; and (iv) immunoreactive cells for anti-NS3 in several brain areas47. While these observations were essentially in congruence to our study, the phenotype of infected C57BL/6 mice diverged from our infected mice. In Amaral and coworkers’ model, animals showed symptoms of apathy, stereotyped behavior, seizures and died at the 8th d.p.i., suggesting the induction of an intense encephalitis by the viral infection. The effectiveness of this referred model in promoting such a drastic neurological manifestation may be involved with the following reasons: (i) infection was administered by the intracranial route that obviously resulted in a massive viral load in the host’s CNS; (ii) animals were infected with DENV-3 genotype I and its level of virulence in comparison to the strain we used is unknown; and (iii) divergences of mouse strain susceptibility to DENV (C57BL/6 versus BALB/c) is also unknown. Based on the above reasons, we consider that the histological alterations found in our infected mice resembles the scenario of encephalitis, however in a much more limited fashion that is not able to yield detectable motor alterations or death. Yet, this controlled and relatively slow process by which the virus invades the CNS, spread and promote the specific changes found in our experimental approach can provide us hints about how the neurological manifestations of dengue take place.
Infected animals responded to virus with induction of TCD8-mediated immunity. However, this host response was still unable to clear the virus, as within two d.p.i. the pathogen could able to reach the brain and to promote alteration in the tissue organization. In the normal pathway of infection, infected mosquitoes deliver the virus to the subcutaneous space. What is generally expected when the infection bypasses the innate immunity, is an initial activation of APCs, migration of these activated cells to lymphoid organs and further expansion and distribution of the virus to the circulation. In our approach, the virus could have reached the brain relatively fast (on the 2nd d.p.i.) because it was administered directly by the i.v. route. Also, if we look at the TCD8 activation kinetic, a relevant specific clone expansion was not seen at the 2nd d.p.i., instead, it was detected by the 7th d.p.i. Consistent to this, major perivascular and pia mater infiltrates were detected by the 7th d.p.i. and not by the 2nd d.p.i. Taking together, in this peculiar case, the virus may have took advantage during the initial days of infection to reach and infect the brain while the TCD8 response was still starting to develop.
Neurogliosis found in the brain of infected animals may represent a key finding in dengue neuropathogenesis. Due to morphological changes and increased cell numbers, it became clear that microglial cells (IBA-1+) and astrocytes (GFAP+) were involved in activation processes. Microglial cells are the resident macrophages of the brain and are known to be susceptible to flavivirus infection48. Once activated, microglial cells are thought to act as the first line of defense in the brain tissue as these cells promote antiviral responses to prevent the progression of encephalitis49. In their non-activated physiological state, microglial cells display a ramified surface that is suitable for the constant surveillance of the local environment50. On the other hand, in pathological conditions these cells become activated and proliferate, assuming an ameboid form that is usually characterized as a spherical-shaped cell that carries several phagocytic vacuoles into its cytoplasm51. Activated microglia release many factors that contribute to inflammation and tissue repair52,53, however, exacerbated reactions of these cells are implicated with massive production and release of IFN-γ, TNF-α and nitric oxide, which can be toxic to neurons. In fact, it represents a mechanistic arm that influences several CNS pathologies, such as multiple sclerosis54,55, Alzheimer’s disease56 and Parkinson’s disease57. In our experimental approach, it is also likely that microglial cells can function as a “double-edged sword” either by acting protectively when promoting the initial antiviral response, or by mediating local damage or dysfunction in cases of signaling exacerbation. Reactive gliosis was also characterized in our experimental approach of infection by the presence of clusters of astrocytes (GFAP+ cells). Astrocytes are the most abundant cells in the CNS and act cooperatively with microglia to stimulate T-cell responses58. Divergences in morphology, when we compared infected to non-infected samples, also suggested activation of this cell subpopulation upon DENV infection. However, in spite of limitations considering the used cell marker59 and the controversial behavior typical of astrocytes in promoting/inhibiting inflammation60, more investigation is needed to better characterize the contribution of these cells in the considered scenario.
Other findings that were implicated with the establishment of neuropathological processes were resultant from the ultrastructural analyses. We observed that neurons, microglia and astrocytes in the brain/cerebellum areas of infected mice exhibited cellular alterations (mainly mitochondria swelling) that indicated processes of apoptotic cell death. The induction of apoptosis by DENV in susceptible cells is well reported in the literature61–64. Particularly, mitochondria swelling in response to DENV was previously characterized under other circumstances such as in peripheral organs of dengue fatal cases65 and in human hepatoma cell line (Hep-G2)66. Similarly to other viral diseases, DENV proteins could also interact with mitochondrias and somehow result in the modulation of apoptotic processes67,68. Given the central role of the brain in receiving information from the body, interpreting and then guiding the body’s response to it, the elimination of brain cells by apoptotic processes could be critical depending on the affected areas. As these target cells, neurons and neuroglial cells, are located within the cerebral cortex and white matter, respectively, it is reasonable to suggest that DENV infection could potentially impact the host’s sensory and/or motor functions. An additional effect that could also potentially commit the motor functions is the demyelination found in the cerebellar tissue. Previous studies suggested that there is a connection between the disruption of the myelin sheath and the activation of microglia69, nonetheless, in dengue this phenomenon is still unknown.
In conclusion, we observed that DENV-2 strain 66985 isolated from the patient and subsequently administered by the i.v. route in mice was able to cause dysfunction in the blood-brain barrier and to replicate in endothelial cells of the brain. This occurred in association with tissue damage/disorganization of CNS structures, reactive gliosis and induction of apoptotic cell death. It is important to note that not all dengue infections lead to neurological manifestations, hence, the phenomena observed in this work could be influenced by the viral strain or even by the applied dose. The experimental approach of infection presented in this work reaffirmed the neurotropic nature of the considered DENV strain in mice and shed light into possible existing CNS changes that may justify neurological manifestations in dengue disease.
Methods
Virus
The virus used in our experiments was the DENV-2 strain BR/RJ66985/2000 representing the linage I isolated from human serum samples at Laboratório de FlavivÃrus/Instituto Oswaldo Cruz (IOC)/Fiocruz/Rio de janeiro/Brazil. The BR/RJ66985/2000 strain (GenBank register number: #HQ012518) was isolated in 05/05/2000 from a 39-year-old male patient that presented classic dengue70. Viruses were propagated in Aedes albopictus mosquito cell line (C6/36) using L-15 medium (Sigma, USA) supplemented with 1% non-essential amino acids, 10% tryptose phosphate broth solution and 10% fetal bovine serum. Infected cells were cultured at 28 °C for 15 days. Viruses were isolated and identified by indirect immunofluorescence technique using 3H5 monoclonal antibody which is type-specific for DENV-271. Finally, the progeny viruses were titrated in C6/36 cells according to Reed and Muench method72.
Ethics in experimental procedures and mice infection
All experiments with mice were conducted in compliance with Ethical Principles in Animal Experimentation stated in the Brazilian College of Animal Experimentation and approved by the Institute’s Animal Use Ethical Committee (acceptance protocol P-12/11-3). Mice were grouped with n = 12.
Adult male BALB/c mice, 2 months old, received 20 μl of DENV-2 at a concentration of 100 TCID50 intravenously by the caudal vein. On the 2nd or 7th day post infection (d.p.i.), animals were anesthetized with a mixture of ketamine-xylazine73, sacrificed and then brain and cerebellum tissues were collected for further analysis (optical and electron microscopy). Brains and cerebellums used as controls (mock) were collected from mice that received cell culture (C6/36) supernatants only by the same route and sacrificed at the 7th d.p.i.
Flow cytometry
For flow cytometry analysis, leukocytes were isolated from blood and spleen. Spleens were dissociated in wire mesh screens using RPMI medium. Spleen macerates and total blood samples were treated with BD FACS Lysing for red blood cell lysis and fixation according to manufacturer’s instructions (BD Biosciences, USA). Cells were spinned down, washed and suspended in PBS/BSA 1%. Approximately 106 cells were stained on ice for 20 min in the dark with the following mab combinations: (i) CD11c-PE and CD86-FITC; or (ii) CD4-PE, CD8-PerCP and CD45RB-FITC. All mabs used in this work were obtained from BD Biosciences and background-staining controls were performed using isotypes recommended by the manufacturer. Samples were read in a BD Accuri C6 flow cytometer and analyzed offline with C6 software (BD Biosciences).
Histopathological analysis
Staining protocol
Histological analyses were carried out based as previously described by Paes and colleagues26. Briefly, fragments of brain and cerebellum collected from mice were fixed in 10% buffered formalin, cleaved into smaller fragments, dehydrated in ethanol, clarified in xylene and blocked in paraffin resin. In sequence, samples were sectioned in 5-μm thick units, deparaffinized in xylene and rehydrated with alcohol. Samples were stained with hematoxylin and eosin (H.E.) and visualized under a light microscopy (Olympus BX 53 F, Japan). Digital images were rendered using Image Pro Plus software version 4.5.
Quantification of damage
Three types of damage were considered for quantification: hemorrhage, perivascular infiltrate and pia mater infiltrate. Histological brain cuts of animals belonging to each analyzed group (mock, 2nd d.p.i. or 7th d.p.i. -4 animals per group) had 30 images randomly captured at 400× magnification using Image Pro software version 4.5. Tissue damages were quantified and qualified in each of the 30 images as: 0 - absent; 1 - light and focal; 2 - light; 3 - moderate; and 4 - diffuse. Infected animals considered in this analysis were positive for DENV-NS3 immunohistochemical reaction in the brain (see “Immunohistochemistry” section in “Methods”).
Ultrastructural analysis
For electron microscopy, fragments of brain and cerebellum were post fixed with 2.5% glutaraldehyde in sodium cacodylate buffer (0.2 M, pH 7.2), dehydrated in acetone, post fixed with 1% buffered osmium tetroxide, embedded in EPON and polymerized at 60 °C for three days. Semi-thin sections (0.5 μm thick) were obtained using a diamond knife (Diatome, Switzerland) adapted to a Reichert-Jung Ultracut E microtome (Markham, Canada) and stained with methylene blue. Ultra-thin sections (60–90 nm) were contrasted with uranyl acetate74 and lead citrate75 and observed under a JEOL-JEM-1011 transmission electron microscope.
Immunohistochemistry
Staining protocol
For immunohistochemical studies, the paraffin-embedded tissues were cut (5 μm thick), incubated at 60 °C for one hour, deparaffinized in xylene and rehydrated with alcohol. Antigen retrieval was performed by heating the tissue in the presence of citrate buffer. Next, tissues were blocked for endogenous peroxidase with 3% hydrogen peroxidase in methanol for 10 minutes and rinsed in tris-HCl (pH 7.4). To reduce non-specific binding, sections were incubated in Protein Blocker solution (Spring Bioscience, USA) for 10 min at room temperature. Afterwards, samples were incubated overnight at 4 °C with primary antibodies: (i) anti-IBA1 antibody (1:200, Wako) to recognize microglia cells; or (ii) anti-GFAP antibody (1:300, Sigma) for astrocyte staining; or (iii) anti-NS3 antibody (diluted 1:100, to detect the DENV-infected cells. In the next day, sections were incubated with secondary complement (REVEAL complement - Spring Bioscience) for 10 minutes and with a rabbit anti-mouse IgG-HRP conjugate (REVEAL polyvalent HRP - Spring Bioscience) for 15 minutes at room temperature. Reactions were revealed with diaminobenzidine (Spring Biosciense) as a chromogen and then sections were counterstained with Meyer’s hematoxylin (Dako). Finally, samples were analyzed under an Olympus BX 53 microscope and frames were acquired using a coupled Olympus DP72 camera.
Quantification of positive cells
For each specific staining (IBA-1 and GFAP) 50 images were randomly captured at 1000× magnification using Image Pro software version 4.5. Positive cells were quantified in each of the 50 images and the median of positive cell number was determined. All analyzes were accomplished in a blind test without prior knowledge of the studied groups. After quantification, frames exhibited in figures were selected as to be more informative according to specific areas in the analyzed tissues.
Immunofluorescence assay
The paraffin-embedded tissues were cut (5 μm thick), incubated at 60 °C for one hour, deparaffinized in xylene and rehydrated with alcohol. Antigen retrieval was performed by heating the tissue in the presence of citrate buffer. The sections were permeabilized for 10 minutes with 0.5% Triton X-100, and incubated for 30 minutes with 2% bovine serum albumin (BSA) and 5% normal goat serum (NGS) for blocking, at room temperature. In sequence, slides were co-stained overnight at 4 °C with anti-F4/80 (eBioscience) and anti-NS365 (in-house produced antibody) antibodies diluted at 1:200 and 1:100, respectively. Sections were washed in PBS and incubated with Alexa 488-conjugated rabbit anti-mouse IgG (Thermo Scientific) or with Alexa 555-conjugated goat anti-rabbit IgG (Thermo Scientific, USA). Samples were analyzed under a Zeiss LSM 510 Meta confocal microscope (Zeiss, Germany).
Quantitative polimerase chain reaction (qPCR)
DENV viral titers in the brain of mice were estimated by using the quantitative qPCR system Taqman (PE Applied Biosystems, Foster City, CA, USA) according to the protocol described by Johnson and coworkers76. For the analysis by molecular techniques, the viral RNA was extracted from samples using the QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany) following the manufacturer’s instructions. The estimated limit of detection for the technique was 1.0 × 10−5 DENV2-RNA copies per mL.
Statistical Analysis
Data obtained from the quantification of positive cells in the immunohistochemistry were analyzed with GraphPad prism software v5.1 (La Jolla, USA) using non-parametric statistical tests. Significant differences between analyzed groups (mock, 2nd d.p.i. and 7th d.p.i.) were determined using Mann-Whitney test with *p < 0.05.
Data Availability
All data generated or analyzed during this study are included in this published article.
Electronic supplementary material
Acknowledgements
We thank the Brazilian foundation FAPERJ (grant number: E-26/110.511/2014 and E-26/202.003/2016) and CNPq (grant number: 30382202015-5) for the financial support and Geraldo C. Wagner from Universidade Federal do Estado do Rio de Janeiro (UNIRIO) for the help with slides production. We also acknowledge the Laboratory of Flaviviruses, Fiocruz, Rio de Janeiro, Brazil, for kindly providing us the DENV-2 samples isolated from patient.
Author Contributions
M.V.P., E.R.A.O., and N.G.S. conceptualized the work; M.V.P., E.R.A.O. and N.G.S. performed the formal analyses; N.G.S., M.V.P. and E.R.A.O. participated directly in the investigation; N.G.S., K.R., M.V.P., T.F.P., E.R.A.O., A.M.B.A., S.M.C., A.J.S.G., J.F.A., A.S.A., P.C.G.N., C.A.B., R.P.B., C.G.F. and L.H.M.G. performed the experiments; M.V.P., R.M.B., E.M.S., C.A.B., R.P.B., F.B.S. and P.C.G.N. provided resources; N.G.S., M.V.P. and E.R.A.O. supervised the results; M.V.P. provided funding acquisition and administrated the project; N.G.S. and E.R.A.O. wrote the original draft of the paper; M.V.P., E.R.A.O., L.H.M.G., F.R.S.L., and K.R. reviewed and edited the paper.
Competing Interests
The authors declare no competing interests.
Footnotes
Edson R. A. Oliveira and Marciano V. Paes contributed equally to this work.
Electronic supplementary material
Supplementary information accompanies this paper at 10.1038/s41598-018-28137-y.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Edson R. A. Oliveira, Email: edsonrao@gmail.com
Marciano V. Paes, Email: marciano@ioc.fiocruz.br
References
- 1.Bhatt S, et al. The global distribution and burden of dengue. Nature. 2013;496:504–507. doi: 10.1038/nature12060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Katzelnick L, Coloma J, Harris E. Dengue: knowledge gaps, unmet needs, and research priorities. Lancet Infect Dis. 2017;17:e88–e100. doi: 10.1016/S1473-3099(16)30473-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Gluber D. The economic burden of dengue. Am J Trop Med Hyg. 2012;86:743–744. doi: 10.4269/ajtmh.2012.12-0157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Sanguansermsri, T., Poneprasert, B. & Phornphutkul, B. Acute encephalopathy associated with dengue infection. Seameo tropmed, 10–11 (1976).
- 5.Patey O, Ollivaud L, Breuil J, Lafaix C. Unusual neurologic manifestations occurring during dengue fever infection. Am J Trop Med Hyg. 1993;48:793–802. doi: 10.4269/ajtmh.1993.48.793. [DOI] [PubMed] [Google Scholar]
- 6.Puccioni-Sohler M, et al. Neurologic dengue manifestations associated with intrathecal specific immune response. Neurology. 2009;73:1413–1417. doi: 10.1212/WNL.0b013e3181bd8258. [DOI] [PubMed] [Google Scholar]
- 7.Ramos C, et al. Dengue virus in the brain of a fatal case of hemorrhagic dengue fever. J Neurovirol. 1998;4:465–468. doi: 10.3109/13550289809114548. [DOI] [PubMed] [Google Scholar]
- 8.Miagostovich MP, et al. Diagnosis of dengue by using reverse transcriptase-polymerase chain reaction. Mem Inst Oswaldo Cruz. 1997;92:595–599. doi: 10.1590/S0074-02761997000500006. [DOI] [PubMed] [Google Scholar]
- 9.Miagostovich MP, et al. Retrospective study on dengue fatal cases. Clin Neuropathol. 1997;16:204–208. [PubMed] [Google Scholar]
- 10.Angibaud G, Luaute J, Laille M, Gaultier C. Brain involvement in dengue fever. J Clin Neurosci. 2001;8:63–65. doi: 10.1054/jocn.2000.0735. [DOI] [PubMed] [Google Scholar]
- 11.Araújo F, et al. Detection of the dengue non-structural 1 antigen in cerebral spinal fluid samples using a commercially available enzyme-linked immunosorbent assay. J Virol Methods. 2011;177:128–131. doi: 10.1016/j.jviromet.2011.07.003. [DOI] [PubMed] [Google Scholar]
- 12.Lima DM, et al. A DNA vaccine candidate encoding the structural prM/e proteins elicits a strong immune response and protects mice against dengue-4 virus infection. Vaccine. 2011;29:831–838. doi: 10.1016/j.vaccine.2010.10.078. [DOI] [PubMed] [Google Scholar]
- 13.Murthy JMK. Neurological complication of dengue infection. Neurol India. 2010;58:581. doi: 10.4103/0028-3886.68654. [DOI] [PubMed] [Google Scholar]
- 14.Mamdouh K, Mroog K, Hani N, Nabil E. Atypical dengue meningitis in makkah, saudi arabia with slow resolving, prominent migraine like headache, phobia, and arrhythmia. J Glob Infect Dis. 2013;5:183. doi: 10.4103/0974-777X.122021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Sahu R, et al. Neurologic complications in dengue virus infection: A prospective cohort study. Neurology. 2014;83:1601–1609. doi: 10.1212/WNL.0000000000000935. [DOI] [PubMed] [Google Scholar]
- 16.Saini L, et al. Dengue fever triggering hemiconvulsion hemiplegia epilepsy in a child. Neurol India. 2017;65:636. doi: 10.4103/neuroindia.NI_57_16. [DOI] [PubMed] [Google Scholar]
- 17.Solomon T, et al. Neurological manifestations of dengue infection. Lancet. 2000;355:1053–1059. doi: 10.1016/S0140-6736(00)02036-5. [DOI] [PubMed] [Google Scholar]
- 18.Domingues R, et al. Involvement of the central nervous system in patients with dengue virus infection. J Neurol Sci. 2008;1–2:36–40. doi: 10.1016/j.jns.2007.09.040. [DOI] [PubMed] [Google Scholar]
- 19.Cam B, et al. Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. Am J Trop Med Hyg. 2001;65:848–851. doi: 10.4269/ajtmh.2001.65.848. [DOI] [PubMed] [Google Scholar]
- 20.Pancharoen C, Thisyakorn U. Neurological manifestations in dengue patients. Southeast Asian J Trop Med Public Health. 2001;32:341–345. [PubMed] [Google Scholar]
- 21.Thisyakorn U, Thisyakorn C. Dengue infection with unusual manifestations. J Med Assoc Thai. 1994;77:410–413. [PubMed] [Google Scholar]
- 22.Thisyakorn U, Thisyakorn C, Limpitikul W, Nisalak A. Dengue infection with central nervous system manifestations. Southeast Asian J Trop Med Public Health. 1999;30:504–506. [PubMed] [Google Scholar]
- 23.Carod-Artal FJ, Wichmann O, Farrar J, Gascón J. Neurological complications of dengue virus infection. Lancet Neurol. 2013;12:906–919. doi: 10.1016/S1474-4422(13)70150-9. [DOI] [PubMed] [Google Scholar]
- 24.Huy N, et al. Factors associated with dengue shock syndrome: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2013;7:e2412. doi: 10.1371/journal.pntd.0002412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.WHO. Dengue: guidelines for diagnosis, treatment, prevention and control - new edition. WHO Library Cataloguing-in-Publication Data, Geneva, Switzerland (2009). [PubMed]
- 26.Paes MV, et al. Hepatic damage associated with dengue-2 virus replication in liver cells of balb/c mice. Lab Invest. 2009;89:1140–1151. doi: 10.1038/labinvest.2009.83. [DOI] [PubMed] [Google Scholar]
- 27.García-Rivera EJ, Rigau-Pérez JG. Dengue virus infection increases microglial cell migration. Lancet. 2002;360:261. doi: 10.1016/S0140-6736(02)09481-3. [DOI] [PubMed] [Google Scholar]
- 28.Garman RH. Histology of the central nervous system. Toxicol Pathol. 2011;39:22–35. doi: 10.1177/0192623310389621. [DOI] [PubMed] [Google Scholar]
- 29.Newman EA. New roles for astrocytes: regulation of synaptic transmission. Trends Neurosci. 2003;26:536–542. doi: 10.1016/S0166-2236(03)00237-6. [DOI] [PubMed] [Google Scholar]
- 30.Jessen KR, Mirsky R. The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci. 2005;6:671–682. doi: 10.1038/nrn1746. [DOI] [PubMed] [Google Scholar]
- 31.Ashour J, et al. Mouse STAT2 restricts early dengue virus replication. Cell Host Microbe. 2010;8:410–421. doi: 10.1016/j.chom.2010.10.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Aguirre S, et al. DENV inhibits type i IFN production in infected cells by cleaving human STING. PLoS Pathog. 2012;8:e1002934. doi: 10.1371/journal.ppat.1002934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Yu C-Y, et al. Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog. 2012;8:e1002780. doi: 10.1371/journal.ppat.1002780. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Diamond MS, Harris E. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology. 2001;289:297–311. doi: 10.1006/viro.2001.1114. [DOI] [PubMed] [Google Scholar]
- 35.Diamond MS, et al. Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol. 2000;74:4957–4966. doi: 10.1128/JVI.74.11.4957-4966.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci USA. 2003;100:14333–14338. doi: 10.1073/pnas.2335168100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Jones M, et al. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol. 2005;79:5414–5420. doi: 10.1128/JVI.79.9.5414-5420.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Munoz-Jordan JL, et al. Inhibition of alpha/beta interferon signaling by the NS4b protein of flaviviruses. J Virol. 2005;79:8004–8013. doi: 10.1128/JVI.79.13.8004-8013.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Ashour J, Laurent-Rolle M, Shi P-Y, Garcia-Sastre A. NS5 of dengue virus mediates STAT2 binding and degradation. J Virol. 2009;83:5408–5418. doi: 10.1128/JVI.02188-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Mazzon M, Jones M, Davidson A, Chain B, Jacobs M. Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J Infect Dis. 2009;200:1261–1270. doi: 10.1086/605847. [DOI] [PubMed] [Google Scholar]
- 41.Morrison J, Aguirre S, Fernandez-Sesma A. Innate immunity evasion by dengue virus. Viruses. 2012;4:397–413. doi: 10.3390/v4030397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Morrison J, et al. Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type i interferon signaling. PLoS Pathog. 2013;9:e1003265. doi: 10.1371/journal.ppat.1003265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Chen H-C, Hofman FM, Kung JT, Lin Y-D, Wu-Hsieh BA. Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol. 2007;81:5518–5526. doi: 10.1128/JVI.02575-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Chen H-C, et al. Lymphocyte activation and hepatic cellular infiltration in immunocompetent mice infected by dengue virus. J Med Virol. 2004;73:419–431. doi: 10.1002/jmv.20108. [DOI] [PubMed] [Google Scholar]
- 45.Oliveira E, et al. Peripheral effects induced in BALB/c mice infected with DENV by the intracerebral route. Virology. 2016;489:95–107. doi: 10.1016/j.virol.2015.12.006. [DOI] [PubMed] [Google Scholar]
- 46.Paes M, et al. Liver injury and viremia in mice infected with dengue-2 virus. Virology. 2005;338:236–246. doi: 10.1016/j.virol.2005.04.042. [DOI] [PubMed] [Google Scholar]
- 47.Amaral DC, et al. Intracerebral infection with dengue-3 virus induces meningoencephalitis and behavioral changes that precede lethality in mice. J Neuroinflammation. 2011;8:23. doi: 10.1186/1742-2094-8-23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Thongtan T, et al. Characterization of putative japanese encephalitis virus receptor molecules on microglial cells. J Med Virol. 2012;84:615–623. doi: 10.1002/jmv.23248. [DOI] [PubMed] [Google Scholar]
- 49.Tsai TT, et al. Microglia retard dengue virus-induced acute viral encephalitis. Sci Rep. 2016;6:27670. doi: 10.1038/srep27670. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Kettenmann H, Hanisch U-K, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev. 2011;91:461–553. doi: 10.1152/physrev.00011.2010. [DOI] [PubMed] [Google Scholar]
- 51.Boche D, Perry VH, Nicoll JAR. Review: Activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol. 2013;39:3–18. doi: 10.1111/nan.12011. [DOI] [PubMed] [Google Scholar]
- 52.Michell-Robinson MA, et al. Roles of microglia in brain development, tissue maintenance and repair. Brain. 2015;138:1138–1159. doi: 10.1093/brain/awv066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Nayak D, Roth TL, McGavern DB. Microglia development and function. Annu Rev Immunol. 2014;32:367–402. doi: 10.1146/annurev-immunol-032713-120240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Giovannoni G, Heales SJ, Land JM, Thompson EJ. The potential role of nitric oxide in multiple sclerosis. Mult Scler. 1998;4:212–216. doi: 10.1177/135245859800400323. [DOI] [PubMed] [Google Scholar]
- 55.Hofman FM, Hinton DR, Johnson K, Merrill. J Exp Med. 1989. Tumor necrosis factor identified in multiple sclerosis brain; pp. 607–612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Rogers J, Luber-Narod J, Styren SD, Civin WH. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer’s disease. Neurobiol Aging. 1988;9:339–349. doi: 10.1016/S0197-4580(88)80079-4. [DOI] [PubMed] [Google Scholar]
- 57.McGeer PL, Itagaki S, Akiyama H, McGeer EG. Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol. 1988;24:574–576. doi: 10.1002/ana.410240415. [DOI] [PubMed] [Google Scholar]
- 58.Jensen CJ, Massie A, Keyser JD. Immune players in the CNS: The astrocyte. J Neuroimmune Pharmacol. 2013;8:824–839. doi: 10.1007/s11481-013-9480-6. [DOI] [PubMed] [Google Scholar]
- 59.Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009;32:638–647. doi: 10.1016/j.tins.2009.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Sofroniew MV. Reactive astrocytes in neural repair and protection. Neuroscientist. 2005;11:400–407. doi: 10.1177/1073858405278321. [DOI] [PubMed] [Google Scholar]
- 61.Torrentes-Carvalho A, et al. Dengue-2 infection and the induction of apoptosis in human primary monocytes. Mem Inst Oswaldo Cruz. 2009;104:1091–1099. doi: 10.1590/S0074-02762009000800005. [DOI] [PubMed] [Google Scholar]
- 62.Liu Y, Liu H, Zou J, Zhang B, Yuan Z. Dengue virus subgenomic RNA induces apoptosis through the bcl-2-mediated PI3k/akt signaling pathway. Virology. 2014;448:15–25. doi: 10.1016/j.virol.2013.09.016. [DOI] [PubMed] [Google Scholar]
- 63.Courageot MP, Catteau A, Desprès P. Mechanisms of dengue virus-induced cell death. Adv Virus Res. 2003;60:157–816. doi: 10.1016/S0065-3527(03)60005-9. [DOI] [PubMed] [Google Scholar]
- 64.Castellanos JE, Neissa JI, Camacho SJ. La infección con el virus del dengue induce apoptosis en células del neuroblastoma humano SH-SY5y. Biomedica. 2016;36:156. doi: 10.7705/biomedica.v36i0.2984. [DOI] [PubMed] [Google Scholar]
- 65.Póvoa TF, et al. The pathology of severe dengue in multiple organs of human fatal cases: Histopathology, ultrastructure and virus replication. PLoS ONE. 2014;9:e83386. doi: 10.1371/journal.pone.0083386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.El-Bacha T, et al. Mitochondrial and bioenergetic dysfunction in human hepatic cells infected with dengue 2 virus. Biochim Biophys Acta. 2007;1772:1158–1166. doi: 10.1016/j.bbadis.2007.08.003. [DOI] [PubMed] [Google Scholar]
- 67.Everett H, McFadden G. Viruses and apoptosis: Meddling with mitochondria. Virology. 2001;288:1–7. doi: 10.1006/viro.2001.1081. [DOI] [PubMed] [Google Scholar]
- 68.Piccoli C, et al. Mitochondrial dysfunction in hepatitis c virus infection. Biochim Biophys Acta. 2006;1757:1429–1437. doi: 10.1016/j.bbabio.2006.05.018. [DOI] [PubMed] [Google Scholar]
- 69.Chatterjee D, Biswas K, Nag S, Ramachandra SG, Sarma JD. Microglia play a major role in direct viral-induced demyelination. Clin Dev Immunol. 2013;2013:1–12. doi: 10.1155/2013/510396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Nunes PCG, et al. Dengue severity associated with age and a new lineage of dengue virus-type 2 during an outbreak in rio de janeiro, brazil. J Med Virol. 2016;88:1130–1136. doi: 10.1002/jmv.24464. [DOI] [PubMed] [Google Scholar]
- 71.Nogueira RM, et al. Dengue epidemic in the stage of Rio de Janeiro, Brazil, 1990-1: co-circulation of dengue 1 and dengue 2 serotypes. Epidemiol Infect. 1993;111:163–170. doi: 10.1017/S0950268800056788. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg. 1938;27:493–497. [Google Scholar]
- 73.Erhardt W, Hebestedt A, Aschenbrenner G, Pichotka B, Blümel G. A comparative study with various anesthetics in mice (pentobarbitone ketamine-xylazine carfentanyl-etomidate) Res Exp Med. 1984;184:159–169. doi: 10.1007/BF01852390. [DOI] [PubMed] [Google Scholar]
- 74.Watson ML. Staining of tissue sections for electron microscopy with heavy metals. J Biophys Biochem Cytol. 1958;4:475–478. doi: 10.1083/jcb.4.4.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Reynolds ES. The use of lead citrate at high ph as an electron-opaque stain in electron microscopy. J Cell Biol. 1963;17:208–212. doi: 10.1083/jcb.17.1.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Johnson BW, Russell BJ, Lanciotti RS. Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay. J Clin Microbiol. 2005;43:4977–4983. doi: 10.1128/JCM.43.10.4977-4983.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data generated or analyzed during this study are included in this published article.